Heart Test Laboratories Inc
General ticker "HSCS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.3B
Heart Test Laboratories Inc does not follow the US Stock Market performance with the rate: -44.3%.
Estimated limits based on current volatility of 7.2%: low 3.32$, high 3.83$
Factors to consider:
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-04-30 to 2026-04-30
- 2024-04-30 to 2025-04-30 estimated range: [2.56$, 9.84$]
- 2025-04-30 to 2026-04-30 estimated range: [1.23$, 4.68$]
Short-term HSCS quotes
Long-term HSCS plot with estimates
Financial data
| YTD | 2022-04-30 | 2023-04-30 | 2024-04-30 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.01MM | $0.02MM |
| Operating Expenses | $4.72MM | $6.12MM | $6.32MM |
| Operating Income | $-4.71MM | $-6.11MM | $-6.31MM |
| Non-Operating Income | $-0.12MM | $-0.24MM | $-0.30MM |
| Interest Expense | $0.37MM | $0.24MM | $0.35MM |
| R&D Expense | $3.00MM | $2.46MM | $2.88MM |
| Income(Loss) | $-4.83MM | $-6.35MM | $-6.61MM |
| Profit(Loss) | $-4.83MM | $-6.35MM | $-6.61MM |
| Stockholders Equity | $-6.06MM | $0.23MM | $7.32MM |
| Inventory | $0.67MM | $0.68MM | $0.63MM |
| Assets | $2.09MM | $3.29MM | $9.50MM |
| Operating Cash Flow | $-3.64MM | $-5.77MM | $-6.07MM |
| Capital expenditure | $0.00MM | $0.02MM | $0.13MM |
| Investing Cash Flow | $-0.00MM | $-0.02MM | $-0.13MM |
| Financing Cash Flow | $3.84MM | $6.53MM | $10.34MM |
| Earnings Per Share* | $-137.94 | $-6,173.88 | $-18.74 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.